Log in to your Inderes Free account to see all free content on this page.
Klaria Pharma Holding
1.08 SEK
-4.41 %
Less than 1K followers
KLAR
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Quarter data
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Klaria Pharma Holding
| Q3/24 | Q4/24 | 2024 | Q1/25 | Q2/25 | Q3/25 | Q4/25 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.3 | 2.3 | 9.0 | 9.0 | ||||
| EBITDA | -2.8 | -23.6 | -31.2 | 3.0 | -14.6 | -6.6 | ||
| EBIT | -2.8 | -23.6 | -31.2 | 3.0 | -14.6 | -6.6 | -7.1 | -25.2 |
| EBIT-% | -1,050.7 % | -1,387.1 % | 33.3 % | -280.7 % | ||||
| Profit before taxes | -4.1 | -28.3 | -47.7 | -1.6 | -20.1 | -8.7 | -8.4 | -38.9 |
| Net income | -7.9 | -24.5 | -47.8 | -1.6 | -20.1 | -8.7 | -8.4 | -38.9 |
Login required
This content is only available for logged in users